Valuation China Resources Pharmaceutical Group Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 02:18:28 2026-07-02 EDT			5-day change	1st Jan Change
4.370 ^HKD	+3.07%		-1.13%	-1.57%

06-28	China Resources Pharmaceutical Unit Sells 2 Billion Yuan Bonds	MT
06-01	China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3%	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	26,638	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	-4.72%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	79,990	74,597	59,240
Change	-	19.71%	-2.67%	26.95%	0.08%	-11.91%	-6.74%	-20.59%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.41x	5.06x	4.71x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.42x	0.39x	0.33x
PEG	-	1x	44.15x	-0.7x	0.2x	0.69x	0.73x	0.64x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.08x	0.08x	0.07x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.25x	0.22x	0.16x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.88x	3.5x	2.86x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.84x	4.23x	3.18x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	45.1x	12.4x	7.08x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	2.22%	8.09%	14.1%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2054	0.2241	0.2821
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.84%	5.29%	6.65%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7839	0.8381	0.8998
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.2%	26.7%	31.4%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	324,714	341,354	359,370
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	20,599	21,289	20,736
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,541	17,648	18,651
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,826	5,222	5,645
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	53,352	47,959	32,603
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.240	4.240	4.240
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	3/29/22	3/30/23	3/26/24	3/26/25	3/24/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.41x	0.25x	3.88x	4.84%	3.4B
ELI LILLY AND COMPANY	34.84x	12.66x	25.79x	0.57%	1,063B
JOHNSON & JOHNSON	27.14x	6.24x	16.98x	2.1%	611B
ABBVIE INC.	30.97x	7.43x	15.19x	2.76%	444B
ROCHE HOLDING AG	17.52x	4.36x	10.71x	3.05%	324B
ASTRAZENECA PLC	22.92x	4.81x	13.47x	1.81%	285B
NOVARTIS AG	21.57x	5.54x	13.39x	2.85%	283B
NOVO NORDISK A/S	14.31x	5.31x	10.9x	3.5%	219B
AMGEN INC.	23.55x	6.27x	11.03x	2.79%	195B
GILEAD SCIENCES, INC.	-44.98x	5.45x	30.27x	2.58%	156B
Average	15.32x	5.83x	15.16x	2.68%	358.41B
Weighted average by Cap.	24.10x	7.86x	18.11x	2%